JPMorgan Chase & Co. Reiterates “Overweight” Rating for Oxford Nanopore Technologies (LON:ONT)

Oxford Nanopore Technologies (LON:ONT)‘s stock had its “overweight” rating reiterated by JPMorgan Chase & Co. in a report released on Thursday, Marketbeat reports.

ONT has been the topic of a number of other reports. Berenberg Bank reaffirmed a “buy” rating and set a GBX 529 ($6.50) target price on shares of Oxford Nanopore Technologies in a research note on Tuesday, August 1st. Royal Bank of Canada reduced their target price on shares of Oxford Nanopore Technologies from GBX 350 ($4.30) to GBX 300 ($3.68) and set an “outperform” rating on the stock in a research note on Monday, November 13th. Finally, Barclays reissued an “overweight” rating and set a GBX 355 ($4.36) target price on shares of Oxford Nanopore Technologies in a research note on Thursday, September 7th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Oxford Nanopore Technologies has a consensus rating of “Buy” and a consensus price target of GBX 392.80 ($4.82).

Oxford Nanopore Technologies Stock Performance

LON ONT opened at GBX 199 ($2.44) on Thursday. The stock’s fifty day moving average is GBX 206.18 and its two-hundred day moving average is GBX 229.04. The firm has a market capitalization of £1.71 billion, a P/E ratio of -1,326.67 and a beta of 0.69. The company has a debt-to-equity ratio of 5.09, a quick ratio of 6.01 and a current ratio of 6.00. Oxford Nanopore Technologies has a fifty-two week low of GBX 169.60 ($2.08) and a fifty-two week high of GBX 294.50 ($3.62).

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.